$-0.24 EPS Expected for Aemetis, Inc. (AMTX)

December 20, 2017 – By Ellis Scott

 $ 0.24 EPS Expected for Aemetis, Inc. (AMTX)

Analysts expect Aemetis, Inc. (NASDAQ:AMTX) to report $-0.24 EPS on December, 25.They anticipate $0.03 EPS change or 14.29 % from last quarter’s $-0.21 EPS. After having $-0.30 EPS previously, Aemetis, Inc.’s analysts see -20.00 % EPS growth. The stock increased 4.95% or $0.0329 during the last trading session, reaching $0.6979. About 10,531 shares traded. Aemetis, Inc. (NASDAQ:AMTX) has declined 50.79% since December 20, 2016 and is downtrending. It has underperformed by 67.49% the S&P500.

Aemetis, Inc. operates as an international renewable fuels and bio-chemicals firm in North America and India. The company has market cap of $13.83 million. It focuses on the production of advanced fuels and chemicals through the acquisition, development, and commercialization of technologies that replace traditional petroleum products by conversion of first-generation ethanol and biodiesel plants into advanced bio refineries. It currently has negative earnings. The firm owns and operates a biodiesel plant in Kakinada, India; and an ethanol plant in Keyes, California.

More notable recent Aemetis, Inc. (NASDAQ:AMTX) news were published by: Businesswire.com which released: “Biofuel Producer Aemetis Partners with Edeniq to Implement Advanced Technology” on November 08, 2012, also Seekingalpha.com with their article: “Aemetis’ (AMTX) CEO Eric McAfee on Q3 2017 Results – Earnings Call Transcript” published on November 12, 2017, Seekingalpha.com published: “Aemetis Has Risks But Is A Bargain At This Price” on November 16, 2015. More interesting news about Aemetis, Inc. (NASDAQ:AMTX) were released by: Seekingalpha.com and their article: “Aemetis – Changes Bring More Potential Upside” published on May 26, 2016 as well as Bizjournals.com‘s news article titled: “St. Louis could be the next energy disruptor, VC says” with publication date: November 16, 2017.

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.